LINC00511 also acts as an oncogene in non–small cell lung cancer [30], tongue squamous cell carcinoma [32], osteosarcoma [35], glioma [36], ovarian cancer [37], and thyroid carcinoma [38]. This evidence concerns the gene LINC00511 and central nervous system cancer.